Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia
Background There are no established therapeutic options available for idiopathic pleuroparenchymal fibroelastosis (IPPFE) apart from supportive care and lung transplantation. Furthermore, it is known that IPPFE with a usual interstitial pneumonia (UIP) pattern and lower lobe predominance is a diseas...
Main Authors: | Keishi Sugino, Hirotaka Ono, Hiroshige Shimizu, Takeyuki Kurosawa, Keiko Matsumoto, Masahiro Ando, Kiyoshi Mori, Eiyasu Tsuboi, Sakae Homma, Kazuma Kishi |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2021-03-01
|
Series: | ERJ Open Research |
Online Access: | http://openres.ersjournals.com/content/7/1/00196-2020.full |
Similar Items
-
Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis
by: Keishi Sugino, et al.
Published: (2021-07-01) -
Lung Transplantation for Pleuroparenchymal Fibroelastosis
by: Haruhiko Shiiya, et al.
Published: (2021-03-01) -
Pleuroparenchymal fibroelastosis presenting with pneumothorax
by: Yen-Yu Lin, et al.
Published: (2018-03-01) -
Transbronchial cryobiopsy for diagnosis of pleuroparenchymal fibroelastosis
by: Abdulrahman Hakami, et al.
Published: (2020-01-01) -
Nintedanib in idiopathic and secondary pleuroparenchymal fibroelastosis
by: Mouhamad Nasser, et al.
Published: (2021-10-01)